Aris Nikolaos Economides

Dr. Aris Nikolaos Economides

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2003 in Endocrine Reviews
Verified
Journal Article
Closed access
ECErnesto Canalis
Ernesto Canalis
AEAris Nikolaos Economides
Aris Nikolaos Economides
EGElisabetta Gazzerro
Elisabetta Gazzerro
Skeletal homeostasis is determined by systemic hormones and local factors. Bone morphogenetic proteins (BMP) are unique because they induce the differentiation of mesenchymal cells toward cells of the osteoblastic lineage and also enhance the differentiated function of the osteoblast. However, the activity of BMPs needs to be tempered by intracellular and extracellular antagonists. BMPs bind to specific receptors and signal by phosphorylating the cytoplasmic proteins mothers against decapentaplegic (Smad) 1 and 5, which form heterodimers with Smad 4, and after nuclear translocation regulate transcription. BMP antagonists can be categorized as pseudoreceptors that compete with signaling receptors, inhibitory Smads that block signaling, intracellular binding proteins that bind Smad 1 and 5, and factors that induce ubiquitination and proteolysis of signaling Smads. In addition, a large number of extracellular proteins that bind BMPs and prevent their binding to signaling receptors have emerged. They are the components of the Spemann organizer, noggin, chordin, and follistatin, members of the Dan/Cerberus family, and twisted gastrulation. The antagonists tend to be specific for BMPs and are regulated by BMPs, indicating the existence and need of local feedback mechanisms to temper BMP cellular activities.

29 October 1993 in Science
Verified
Journal Article
Closed access
PDF file
TLTeresa M. Lamb
Teresa M. Lamb
AKAnne K. Knecht
Anne K. Knecht
WSWilliam C. Smith
William C. Smith
SSScott E. Stachel
Scott E. Stachel
AEAris Nikolaos Economides
Aris Nikolaos Economides
RHRichard M. Harland
Richard M. Harland
The Spemann organizer induces neural tissue from dorsal ectoderm and dorsalizes lateral and ventral mesoderm in Xenopus . The secreted factor noggin, which is expressed in the organizer, can mimic the dorsalizing signal of the organizer. Data are presented showing that noggin directly induces neural tissue, that it induces neural tissue in the absence of dorsal mesoderm, and that it acts at the appropriate stage to be an endogenous neural inducing signal. Noggin induces cement glands and anterior brain markers, but not hindbrain or spinal cord markers. Thus, noggin has the expression pattern and activity expected of an endogenous neural inducer.

1 February 2011 in Developmental Cell
Verified
Journal Article
Closed access
BGBo Gao
Bo Gao
HSHai Song
Hai Song
KBKevin Bishop
Kevin Bishop
GEGene Elliot
Gene Elliot
LGLisa Garrett
Lisa Garrett
YYYingzi Yang
Yingzi Yang

5 May 2003 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
DVDavid M Valenzuela
David M Valenzuela
AMAndrew J Murphy
Andrew J Murphy
DFDavid Frendewey
David Frendewey
NGNicholas W Gale
Nicholas W Gale
AEAris Nikolaos Economides
Aris Nikolaos Economides
GYGeorge D Yancopoulos
George D Yancopoulos

1 April 1998 in Molecular Cell
Verified
Journal Article
Closed access
DHDavid R Hsu
David R Hsu
AEAris Nikolaos Economides
Aris Nikolaos Economides
XWXiaorong Wang
Xiaorong Wang
PEPeter M Eimon
Peter M Eimon
RHRichard M Harland
Richard M Harland

21 October 2020 in Nature
Verified
Journal Article
Open access
PDF file
CHCristopher V. Van Hout
Cristopher V. Van Hout
ITIoanna Tachmazidou
Ioanna Tachmazidou
JBJoshua D. Backman
Joshua D. Backman
JHJoshua D. Hoffman
Joshua D. Hoffman
DLDaren Liu
Daren Liu
ABAris Baras
Aris Baras
The UK Biobank is a prospective study of 502,543 individuals, combining extensive phenotypic and genotypic data with streamlined access for researchers around the world1. Here we describe the release of exome-sequence data for the first 49,960 study participants, revealing approximately 4 million coding variants (of which around 98.6% have a frequency of less than 1%). The data include 198,269 autosomal predicted loss-of-function (LOF) variants, a more than 14-fold increase compared to the imputed sequence. Nearly all genes (more than 97%) had at least one carrier with a LOF variant, and most genes (more than 69%) had at least ten carriers with a LOF variant. We illustrate the power of characterizing LOF variants in this population through association analyses across 1,730 phenotypes. In addition to replicating established associations, we found novel LOF variants with large effects on disease traits, including PIEZO1 on varicose veins, COL6A1 on corneal resistance, MEPE on bone density, and IQGAP2 and GMPR on blood cell traits. We further demonstrate the value of exome sequencing by surveying the prevalence of pathogenic variants of clinical importance, and show that 2% of this population has a medically actionable variant. Furthermore, we characterize the penetrance of cancer in carriers of pathogenic BRCA1 and BRCA2 variants. Exome sequences from the first 49,960 participants highlight the promise of genome sequencing in large population-based studies and are now accessible to the scientific community.